SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-026893 from Neuraxis, INC (NRXS) (CIK 0001933567) (NRXS)

Neuraxis, INC (NRXS) (CIK 0001933567)
Date: Aug. 4, 2023 · CIK: 0001933567 · Accession: 0001493152-23-026893

AI Filing Summary & Sentiment

File numbers found in text: 333-269179

Date
Aug. 4, 2023
Author
CAPITAL, L.P.
Form
CORRESP
Company
Neuraxis, INC (NRXS) (CIK 0001933567)

Letter

Re:

August 4, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attention: Cindy Polynice

Neuraxis, Inc.

Registration Statement on Form S-1

File No. 333-269179

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Alexander Capital, L.P., as representative of the several underwriters, hereby joins Neuraxis, Inc., (the “Company”) in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-269179) (the “Registration Statement”) to become effective on August 8, 2023, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Lucosky Brookman LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Securities Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very
truly yours,
ALEXANDER
CAPITAL, L.P.

Show Raw Text
CORRESP
1
filename1.htm

August
4, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Cindy Polynice

    Re:

    Neuraxis,
    Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-269179

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Alexander Capital, L.P., as representative
of the several underwriters, hereby joins Neuraxis, Inc., (the “Company”) in requesting that the Securities and Exchange
Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-269179) (the “Registration Statement”)
to become effective on August 8, 2023, at 5:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such other
time as the Company or its outside counsel, Lucosky Brookman LLP, request by telephone that such Registration Statement be declared effective.

Pursuant
to Rule 460 under the Securities Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed
to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of
the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The
undersigned advises that it has complied and will continue to comply, and that it has been informed by the participating underwriters
and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange
Act of 1934, as amended.

    Very
    truly yours,

    ALEXANDER
    CAPITAL, L.P.

    By:

    /s/
    Jonathan Gazdak

    Name:

    Jonathan
    Gazdak

    Title:

    Managing
    Director - Head of Investment Banking